Autonomic nervous system response to L-dopa in patients with advanced Parkinson's disease
暂无分享,去创建一个
Mika P. Tarvainen | Pasi A. Karjalainen | Verneri Ruonala | Eero Pekkonen | Saara M. Rissanen | E. Pekkonen | M. Tarvainen | P. Karjalainen | S. Rissanen | Verneri Ruonala
[1] M. Breteler,et al. Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.
[2] G. Breithardt,et al. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .
[3] Hakan Widner,et al. Deep brain stimulation for Parkinson's disease: Patient selection and evaluation , 2002, Movement disorders : official journal of the Movement Disorder Society.
[4] Mika P. Tarvainen,et al. An advanced detrending method with application to HRV analysis , 2002, IEEE Transactions on Biomedical Engineering.
[5] A. Benabid,et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD , 2002, Neurology.
[6] A. Lipp,et al. Cardiovascular effects of levodopa in Parkinson's disease. , 2014, Parkinsonism & related disorders.
[7] A. Alessandri,et al. Twenty‐four‐hour heart rate variability to assess autonomic function in Parkinson's disease , 1999, Acta neurologica Scandinavica.
[8] O. Rascol,et al. Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.
[9] A. Destée,et al. Heart rate variability and Parkinson’s disease severity , 2003, Journal of Neural Transmission.
[10] Mika P. Tarvainen,et al. Kubios HRV - Heart rate variability analysis software , 2014, Comput. Methods Programs Biomed..
[11] J. Korpelainen,et al. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease , 2000, Journal of Neurology.
[12] H. Nagaraja,et al. Heart rate variability: origins, methods, and interpretive caveats. , 1997, Psychophysiology.
[13] D. Calne,et al. Hypotension Caused by L-Dopa , 1970, British medical journal.
[14] L. Rumbach,et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of l-dopa therapy , 2004, Autonomic Neuroscience.
[15] L. Schiffer,et al. Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.